CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans

BACKGROUND: CTLA4 blocking monoclonal antibodies provide durable clinical benefit in a subset of patients with advanced melanoma mediated by intratumoral lymphocytic infiltrates. A key question is defining if the intratumoral infiltration is a differentiating factor between patients with and without...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Huang, Rong Rong, Jalil, Jason, Economou, James S., Chmielowski, Bartosz, Koya, Richard C., Mok, Stephen, Sazegar, Hooman, Seja, Elizabeth, Villanueva, Arturo, Gomez-Navarro, Jesus, Glaspy, John A., Cochran, Alistair J., Ribas, Antoni
Formato: Artigo
Idioma:Inglês
Publicado: 2011
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3117971/
https://ncbi.nlm.nih.gov/pubmed/21558401
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0407
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares